CClinicalTrials.gg
RecruitingNCT07389681EPSOCOTUpdated Jun 5, 2026

Management of Bone Loss in Orthopaedic Surgery Using the Masquelet Technique or Transport Nails

An interventional study of Data collection and self-administered questionnaire. in Critical-size Bone Defect, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a single-center prospective observational study comparing two techniques for reconstructing bone loss in the lower limbs. The aim of the study was to compare the results of reconstructions using the Masquelet technique with reconstructions using electromagnetic transport nails. The primary endpoint was time to bone healing. This study is the first prospective descriptive study of electromagnetic transport nails.

Read the detailed description

Segmental bone defects pose a major challenge in orthopaedics due to various causes like trauma, oncology resections, or chronic osteomyelitis. Reconstruction techniques are complex, with Masquelet's method being the most widely used in France, despite mixed outcomes and complications. A novel electromagnetic bone transport technique via intramedullary nailing has emerged as a promising alternative. The primary goal of the study is to compare consolidation times between these two approaches for metaphyseal-diaphyseal bone loss in the lower limbs. Secondary objectives include assessing patient demographics, functional outcomes, quality of life, hospital stays, and adverse events.

02

Conditions studied

  • Critical-size Bone Defect

Keywords

  • Bone transport
  • Critical-size bone defects
  • Distraction osteogenesis
  • Induced-membrane technique
  • Masquelet technique
03

In context

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient ≥ 18 years
  • Minor patient, able to consent to data collection, with the consent of the owner(s)
  • Patient consulting for a medical reason involving a loss of bone substance in the lower limb in an investigating centre linked to one of these aetiologies for which a reconstruction procedure using a transport nail or Masquelet technique is envisaged:

    • Tumour pathologies requiring
    • Septic or aseptic pseudarthrosis
    • Traumatic pathology
    • Infectious pathologies

Exclusion criteria

Exclusion Criteria:

  • Patients under guardianship or curatorship,
  • Individuals deprived of their liberty by judicial or administrative decision,
  • Individuals receiving involuntary psychiatric care requiring the consent of their legal representative,
  • Individuals unable to express their consent,
  • Individuals under legal protection,
  • Patients with an indication for bone reconstruction using a technique other than the Masquelet technique and nail transport,
  • Patients not covered by a social security scheme,
  • Patients ineligible for bone reconstruction due to their comorbidities
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Other
    Masquelet's method

    Patient consulting for a medical reason involving a loss of bone substance in the lower limb in an investigating centre linked to one of these aetiologies for which a reconstruction procedure using a Masquelet technic is envisaged

    Other: Data collection and self-administered questionnaire.

  • Other
    Transport nail

    Patient consulting for a medical reason involving a loss of bone substance in the lower limb in an investigating centre linked to one of these aetiologies for which a reconstruction procedure using a transport nail is envisaged

    Other: Data collection and self-administered questionnaire.

Interventions

  • OtherData collection and self-administered questionnaire.

    Exhaustive collection of data in a health data warehouse: collection of clinical, radiological examinations (standard of care), functionals scores and self- administered questionnaire (quality of life).

06

What researchers measure

Primary outcomes

  1. Rate of radiological consolidation

    Radiological consolidation is defined by an anteroposterior and lateral radiograph showing at least three out of four cortical plates consolidated. This assessment is performed during follow-up by the physician treating the patient and will be confirmed by an evaluation committee at a later stage.

    Time frame: From enrollment to 36 months after

Secondary outcomes

  1. Functional outcomes : score MSTS

    Functional recovery assessed using MSTS (Musculoskeletal Tumor Society Score). It is composed of 6 items , each item on a scale of 0 to 5, with a higher score indicating better function. The total score, ranging from 0 (maximum disability) to 30 (no disability), can be converted to a point scale from 0 to 100.

    Time frame: Baseline, 12 months, 24 months and 36 months

  2. Time to full weight-bearing

    Time from initial reconstructive surgery to full weight-bearing without assistive devices, as assessed during routine clinical follow-up.

    Time frame: Baseline, 3 months, 6 months, 12 months, 24 months and 36 months

  3. . Functional outcomes : score LEFS

    Functional recovery assessed using Lower Extremity Functional Scale (LEFS). It is composed of 20 items , each item on a scale of 0 to 4, with a higher score indicating better function and total score from 0 to 80.

    Time frame: Baseline, 12 months, 24 months and 36 months

  4. Functional outcomes : paley Marr score.

    Functional recovery assessed using Paley-Maar score. This score is defined from "excellent" to "poor"in fonction of pain, autonomous, ....

    Time frame: Baseline, 12 months, 24 months and 36 months

  5. Quality of life

    Health-related quality of life evaluated using the SF-36 questionnaire. This questionnaire is composed of 11 items and total score from 0 to 100.

    Time frame: Baseline, 12 months, 24 months and 36 months

  6. Adverse events and complications

    Occurrence and type of adverse events and complications, including infections, mechanical failures, nonunion, and need for revision surgery.

    Time frame: 3 months, 6 months, 12 months, 24 months and 36 months

  7. Bone consolidation rate

    Proportion of patients achieving radiological bone consolidation, defined as healing of at least 3 of 4 cortices on standard anteroposterior and lateral radiographs.

    Time frame: From enrollment to 36 months after

07

Study locations

1 of 1 sites recruiting
  • CHU de Bordeaux
    Bordeaux, 33000, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07389681
Lead sponsor
University Hospital, Bordeaux
Responsible party
Sponsor
First posted
Feb 5, 2026
Start date
Apr 27, 2026
Primary completion
Mar 2029 (estimated)
Completion
Mar 2034 (estimated)
Last update
Jun 5, 2026

Study contacts

Benjamin BOUYER, PROF
Contact
b.bouyer@chu-bordeaux.fr
+335 56 79 87 18
Romain HUGUET
Contact
romain.huguet@chu-bordeaux.fr
Benjamin BOUYER, PROF
principal investigator · University Hospital, Bordeaux

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion